Title: Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data
Authors: D'Urzo, Anthony D ×
Kerwin, Edward M
Chapman, Kenneth R
Decramer, Marc
DiGiovanni, Robert
D'Andrea, Peter
Hu, Huilin
Goyal, Pankaj
Altman, Pablo #
Issue Date: 2015
Publisher: DOVE Medical Press
Series Title: International Journal of Chronic Obstructive Pulmonary Disease vol:10 pages:1599-1612
Article number: 10.2147/COPD.S81266
Abstract: Chronic use of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD) has raised long-term safety concerns, particularly cardiovascular. Glycopyrronium is a once-daily anticholinergic with greater receptor selectivity than previously available agents.
ISSN: 1178-2005
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Pneumology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
d'Urzo.pdfOA article Published 282KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science